Provided by Tiger Trade Technology Pte. Ltd.

Quanterix Corp

3.64
+0.23006.74%
Post-market: 3.640.00000.00%16:27 EDT
Volume:590.30K
Turnover:2.14M
Market Cap:171.32M
PE:-1.39
High:3.69
Open:3.44
Low:3.44
Close:3.41
52wk High:8.77
52wk Low:2.15
Shares:47.06M
Float Shares:38.02M
Volume Ratio:0.87
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6200
EPS(LYR):-2.5130
ROE:-46.48%
ROA:-16.67%
PB:0.72
PE(LYR):-1.45

Loading ...

Quanterix Corp - Announces CFO Vandana Sriram to Depart

THOMSON REUTERS
·
May 13

Lucent Diagnostics announces collaboration with Tempus AI

TIPRANKS
·
May 07

Analysts Conflicted on These Healthcare Names: Quanterix (QTRX) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
May 07

Quanterix Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 07

Biomarker detection firm Quanterix reaffirms 2026 revenue guidance

Reuters
·
May 07

Quanterix Q1 FY26 net loss narrows to $17.54 million; revenue rises 20% to $36.4 million

Reuters
·
May 07

Quanterix Q1 EPS $(0.37) Beats $(0.45) Estimate, Sales $36.415M Miss $37.221M Estimate

Benzinga Earnings
·
May 07

BRIEF-Quanterix Q1 Net Income USD -17.541 Million

Reuters
·
May 07

Quanterix Releases Financial Results for the First Quarter of 2026

THOMSON REUTERS
·
May 07

Quanterix Q1 Product Revenue USD 25.479 Million

THOMSON REUTERS
·
May 07

Quanterix - Q1 Revenue USD 36.4 Million

THOMSON REUTERS
·
May 07

Quanterix Q1 Basic EPS USD -0.37

THOMSON REUTERS
·
May 07

Quanterix Corp: Reaffirming Its Guidance for 2026

THOMSON REUTERS
·
May 07

Quanterix partners with Tempus to integrate Alzheimer’s blood biomarker test into workflows

Reuters
·
May 06

Lucent Diagnostics Announces Collaboration With Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing Into Clinical Workflows

THOMSON REUTERS
·
May 06

Quanterix Corp expected to post a loss of 54 cents a share - Earnings Preview

Reuters
·
May 05

Press Release: Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

Dow Jones
·
Apr 24

Quanterix schedules first-quarter results conference call

Reuters
·
Apr 24

Quanterix announces annual shareholder meeting via webcast

Reuters
·
Apr 24

Quanterix Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Apr 21